Sun Pharmaceutical Industries Limited (BOM:524715)
India · Delayed Price · Currency is INR 1,845.20
-45.95 (-2.43%)
At close: May 22, 2026
BOM:524715 Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Net Income | 114,794 | 109,290 | 95,764 | 84,736 | 32,727 |
Depreciation & Amortization | 29,379 | 25,073 | 24,906 | 24,771 | 21,090 |
Other Amortization | - | 681.2 | 661.7 | 533.4 | 435.8 |
Loss (Gain) From Sale of Assets | 1,773 | 235.3 | 1,662 | 227.1 | 1,656 |
Asset Writedown & Restructuring Costs | - | - | -1.5 | -10 | -88.7 |
Loss (Gain) From Sale of Investments | -8,636 | -2,514 | -921.9 | 6.2 | 3,126 |
Provision & Write-off of Bad Debts | 634.1 | 1,808 | 905.9 | 2,071 | 175.7 |
Other Operating Activities | -1,074 | 9,383 | -12,248 | -6,122 | 15,133 |
Change in Accounts Receivable | -20,088 | -16,021 | 3,529 | -9,532 | -13,423 |
Change in Inventory | -523 | -1,840 | 5,988 | -12,022 | 3,070 |
Change in Accounts Payable | 10,574 | 5,280 | 2,497 | 11,824 | 3,699 |
Change in Other Net Operating Assets | -2,641 | 9,345 | -1,393 | -46,888 | 22,244 |
Operating Cash Flow | 124,192 | 140,721 | 121,350 | 49,593 | 89,845 |
Operating Cash Flow Growth | -11.75% | 15.96% | 144.69% | -44.80% | 45.61% |
Capital Expenditures | -36,094 | -21,286 | -22,018 | -20,856 | -14,950 |
Sale of Property, Plant & Equipment | 961.2 | 610.1 | 308.4 | 210.1 | 606.1 |
Cash Acquisitions | -34,051 | -2,728 | -1,433 | -46,858 | -7,396 |
Divestitures | - | - | - | - | 238.4 |
Investment in Securities | -51,897 | -38,642 | 9,325 | -16,436 | -37,911 |
Other Investing Activities | 7,641 | 8,698 | 7,123 | 4,503 | 2,101 |
Investing Cash Flow | -113,441 | -53,062 | -6,902 | -79,437 | -57,247 |
Short-Term Debt Issued | 1,199 | - | 1,430 | - | 1,064 |
Long-Term Debt Issued | 52,022 | 33,617 | 45,727 | 81,598 | 16,568 |
Total Debt Issued | 53,221 | 33,617 | 47,157 | 81,598 | 17,632 |
Short-Term Debt Repaid | - | -482 | - | -1,305 | - |
Long-Term Debt Repaid | -35,616 | -44,784 | -82,287 | -30,010 | -45,286 |
Total Debt Repaid | -35,616 | -45,266 | -82,287 | -31,315 | -45,286 |
Net Debt Issued (Repaid) | 17,605 | -11,649 | -35,130 | 50,283 | -27,654 |
Common Dividends Paid | -39,339 | -36,140 | -28,982 | -25,189 | -21,589 |
Other Financing Activities | -3,392 | -31,270 | -2,990 | -1,333 | -2,692 |
Financing Cash Flow | -25,126 | -79,058 | -67,102 | 23,761 | -51,935 |
Foreign Exchange Rate Adjustments | 7,764 | 1,230 | -739.9 | 1,571 | 1,274 |
Miscellaneous Cash Flow Adjustments | 1,627 | -0.3 | 12.9 | 5,667 | 414.5 |
Net Cash Flow | -4,983 | 9,831 | 46,619 | 1,155 | -17,648 |
Free Cash Flow | 88,098 | 119,435 | 99,332 | 28,738 | 74,895 |
Free Cash Flow Growth | -26.24% | 20.24% | 245.65% | -61.63% | 49.78% |
Free Cash Flow Margin | 14.58% | 22.72% | 20.48% | 6.55% | 19.38% |
Free Cash Flow Per Share | 36.68 | 49.78 | 41.40 | 11.98 | 31.21 |
Cash Interest Paid | - | 2,238 | 2,190 | 1,325 | 732.1 |
Cash Income Tax Paid | - | 4,768 | 15,694 | 15,098 | -9,692 |
Levered Free Cash Flow | 61,643 | 82,397 | 75,828 | 7,911 | 75,693 |
Unlevered Free Cash Flow | 63,761 | 83,843 | 77,318 | 8,986 | 76,489 |
Change in Working Capital | -12,678 | -3,236 | 10,621 | -56,618 | 15,591 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.